Search

 
 
 
Akili Grabs $55M, Seeking FDA Approval of First Video Game Therapy

AKILI GRABS $55M, SEEKING FDA APPROVAL OF FIRST VIDEO GAME THERAPY

Akili Interactive Labs has scooped up another pile of cash to help bring its first product to the market-an experimental mobile video...

 
 
 
Merck Immunotherapy Drug Shines In Lung Cancer Study

MERCK IMMUNOTHERAPY DRUG SHINES IN LUNG CANCER STUDY

Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later,...

New immunotherapy drug becomes first ever to DOUBLE survival in lung cancer patients

NEW IMMUNOTHERAPY DRUG BECOMES FIRST EVER TO DOUBLE SURVIVAL IN LUNG CANCER PATIENTS

Merck's Keytruda, given with standard chemotherapy, cut in half the risk of dying or having the cancer worsen, compared to chemo alone...

 
 
 
 
 
 
Despite Pain Drug's Mid-Stage Miss, Adynxx Plans a Larger Phase 3 Test

DESPITE PAIN DRUG'S MID-STAGE MISS, ADYNXX PLANS A LARGER PHASE 3 TEST

An Adynxx pain drug has failed to meet the main goal of a mid-stage study, but the company instead points to results in a subset of...

IMMUNOGEN STOCK CLIMBS ON POSITIVE OVARIAN CANCER DATA

ImmunoGen, released positive efficacy and tolerability data from its FORWARD II trial of its mirvetuximab soravtansine in combination...

 
 
 
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks

BIO ROUNDUP: CMS BACKS CANCER TESTS, RIGHT TO TRY PASSES, ABBVIE SINKS

We'll start this week's roundup with several stories from Washington, D.C. that could have a lasting effect on public health. The FDA...

Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More

BIO ROUNDUP: MELDONIUM SLIP, KRATOM CRACKDOWN, ZINC FINGERS & MORE

The 2018 Winter Olympics will end soon, and we did not skate through these games without a performance-enhancing drug allegation rearing...

 
 
 
The search for new Alzheimer's treatments just faced another setback - here's where researchers are looking now

THE SEARCH FOR NEW ALZHEIMER'S TREATMENTS JUST FACED ANOTHER SETBACK - HERE'S WHERE RESEARCHERS ARE LOOKING NOW

It's been a while since we've had good news in search for new Alzheimer's drugs. On Tuesday, Merck said it was discontinuing one of...

 
 
 
With New Test, Schadt's Sema4 Aims to Broaden Scope of Newborn Screening

WITH NEW TEST, SCHADT'S SEMA4 AIMS TO BROADEN SCOPE OF NEWBORN SCREENING

Sema4, the company that computational geneticist Eric Schadt spun out of the Icahn School of Medicine at Mount Sinai last year, is...

Tax overhaul charge hands Merck 4Q loss despite higher sales

TAX OVERHAUL CHARGE HANDS MERCK 4Q LOSS DESPITE HIGHER SALES

Drugmaker Merck posted a loss of $872 million in the fourth quarter, as a big charge related to the recent U.S. tax overhaul more than...

 
 
 
Merck reports 4Q loss

MERCK REPORTS 4Q LOSS

KENILWORTH, N.J. - Merck is reporting a fourth-quarter loss of $872 million, but its adjusted results topped Wall Street's view. The...

CDC director quits amidst report she purchased tobacco and pharma stock

CDC DIRECTOR QUITS AMIDST REPORT SHE PURCHASED TOBACCO AND PHARMA STOCK

Brenda Fitzgerald has resigned from the CDC amidst a Politico report that she invested not only in Japan Tobacco but also in Merck,...

 
 
 
Scandalous CDC director RESIGNS after caught buying shares of vaccine maker Merck while heading the CDC

SCANDALOUS CDC DIRECTOR RESIGNS AFTER CAUGHT BUYING SHARES OF VACCINE MAKER MERCK WHILE HEADING THE CDC

As yet more proof that the CDC functions as little more than an extension of the corrupt vaccine industry, CDC director Dr. Brenda...